Position in XENE
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$74,465,551
+$40,489,348 QoQ
Shares Held
1,280,577
+68.9% QoQ
Ownership
1.32%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2023
13 quarters on record
Voting authority
Sole 98.2750744391005.ToString("F0")%
Shared 0.ToString("F0")%
None 1.7249255608995009.ToString("F0")%
Common Shares in XENE Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026FRANKLIN RESOURCES INC holds $7,057,408,835 across 166 Biotechnology names. XENE ranks #19 (1.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
2,722,071 | $2,103,180,930 | |
| 2 | ASND |
Ascendis Pharma A/S
|
2,051,948 | $469,342,063 | |
| 3 | INSM |
INSMED Inc
|
2,617,251 | $427,972,880 | |
| 4 | JAZZ |
Jazz Pharmaceuticals plc
|
1,958,940 | $370,337,604 | |
| 5 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
551,132 | $246,102,477 | |
| 6 | BBIO |
BridgeBio Pharma, Inc.
|
2,438,925 | $181,114,568 | |
| 7 | ARGX |
Argenx SE
|
233,493 | $170,508,261 | |
| 8 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
470,390 | $155,637,935 |
All Filings in XENE
Export CSV
13 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $74,465,551 | 1,280,577 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $33,976,203 | 758,059 | Shares | Defined | 2026-02-11 | |
| 2025-09-30 | $27,940,383 | 695,900 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $20,860,384 | 666,466 | Shares | Defined | 2025-08-12 | |
| 2025-03-31 | $16,477,075 | 491,120 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $22,563,128 | 575,590 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $22,280,072 | 565,915 | Shares | Defined | 2024-11-27 | |
| 2024-06-30 | $22,569,944 | 578,865 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $23,345,540 | 542,289 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $13,533,579 | 293,825 | Shares | Defined | 2024-02-09 | |
| 2023-09-30 | $5,896,425 | 172,612 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $6,645,562 | 172,612 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $6,177,676 | 172,609 | Shares | Defined | 2023-05-12 | |
| No filing history on record for this holder in this stock. | ||||||